Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal?

J Hosp Med. 2024 Apr;19(4):339-343. doi: 10.1002/jhm.13238. Epub 2023 Nov 29.
No abstract available

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Buprenorphine* / therapeutic use
  • Humans
  • Substance Withdrawal Syndrome* / drug therapy

Substances

  • Analgesics, Opioid
  • Buprenorphine